Emilia is focused on the invention, development and commercialization of new medical therapies. At Massachusetts General Hospital and Harvard Medical School, her research focused on the development of novel biocompatible coolants to treat sleep apnea, as well as device-based treatments for peripheral neuropathy. Previously she worked in the design, conduct and analysis of clinical trials in dermatology. Emilia was a Fulbright-Schuman scholar to the European Union, where she studied methods of enhancing transatlantic research collaborations and emerging public private partnership models to accelerate medical innovation. She is a TEDx speaker and was honored as part of the Forbes 30 Under 30 Class of 2017 in Healthcare.
Cyrus is passionate about radically disruptive technologies, such as AI, robotics, nanotech, biotech, genetics, IT and cognitive sciences & their impacts on society. While his graduate degree at Harvard focused on International Security, his daily life brought him to lead biotech and robotics global ventures. With the rise of AI, and its universal transformational power, Cyrus embraced the massively positive changes AI can bring to mankind, while realizing at the same time that we have to build much needed safeguards in order for the medium and long-term effects of AI to be beneficial to our species. Cyrus naturally embraced with enthusiasm The Future Society by leading the AI Initiative.
Pedro is interested in the intersection of brain, behavior, and technology. He is the founder and CEO of 14x Innovation Group (14X IG), a behavioral insights management consulting firm that helps organizations increase effectiveness through a unique blend of neuroscience, social psychology, and the Harvard Business School case method. Pedro is a Co-Instructor and Teaching Fellow at Harvard University, where he co-teaches Motivation and Learning Theory. He also facilitates the Management Development Program at the Harvard Graduate School of Education and the interfaculty Mind, Brain, and Behavior thesis workshops for Harvard College seniors. Pedro has been appointed South Carolina’s New Century Scholar by USA Today and the Coca-Cola Foundation, and was a Forbes 30 Under 30 finalist in 2016. He is a winner of the Harvard Leadership in Education Award, a TEDMED delegate, Magellan Scholar, Walker Institute Scholar, City of Columbia Fellow, TEDx speaker, Darla Moore Emerging Leader, and the youngest ever-appointed member of the Board of Directors of the Central Midlands Council of Governments. Pedro is the author of an upcoming book (Fall 2017) on Collaboration by Penguin Random House.
Jessica Cussins is the Director of Research at The Future Society. She graduated in May 2017 with a Master's Degree in Public Policy from the Harvard Kennedy School of Government and a concentration in international and global affairs, science and technology policy. She Chaired The Future Society at HKS in the 2016-17 academic year. While at Harvard, Jessica worked as a Research Assistant at the Program on Science, Technology & Society, and was a Belfer International and Global Affairs Student Fellow working within both the cybersecurity and biosecurity programs. She currently lives in the San Francisco Bay Area and does consulting work on health data and biotech for several technology think tanks. She writes regularly for outlets including The Los Angeles Times, The Huffington Post, and the Pharmaceutical Journal on the ethical, social, and political implications of consequential emerging technologies. She received her BA with Highest Distinction from the University of California, Berkeley.
Eleonore Pauwels is a writer and international science policy expert, who specializes in the governance of emerging and converging technologies. At the Wilson Center, she is the Director of Biology Collectives, within the Science and Technology Innovation Program. Her research focuses on the convergence of transformative technologies such as artificial intelligence, genome-editing, digital bio-engineering and automation technologies. She analyzes the promises and perils that will likely arise with the development of the Internet of Living Things and future networks of intelligent and connected bio-labs. Her work also fosters the democratization of disruptive health technologies, including AI and genomics, and the inclusion of patients and citizens through participatory health design (her Citizen Health Innovators Project). Eleonore regularly testifies before U.S. and European authorities including the U.S. Department of State, NAS, NIH, NCI, FDA, the National Intelligence Council, the European Commission and the UN. But she is also well-versed in communicating complex and novel scientific developments for lay audiences (her TEDxCERN on CRISPR) and her writing has been featured in media outlets such as Nature, The New York Times, The Guardian, Scientific American, Le Monde, Slate and The Miami Herald.